Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS.

Slides:



Advertisements
Similar presentations
STUDENTS PERSPECTIVE ON TRAINING PROGRAMS Joanna Rozynska GSSR, Institute of Philosophy and Sociology Polish Academy of Science 8th Global Forum of Bioethics,
Advertisements

¨ Dr Alain Garcia General Secretary of the Rare Diseases National Plan The second National Plan for Rare Diseases in France
Sarajevo, October 17,   The institution of the Unit was in line with the strategy adopted by the Italian Government in the Region and its work.
European Partnership for Action Against Cancer (EPAAC)
Università degli Studi di Torino Research and International Relations Division TEMPUS Joint European Project PAMIR Irene Liverani Project kick-off meeting.
S3 Project aim The main goal, thus expected result, of the S3 project would be to strengthen tools used for Structural Fund policies (SF), through the.
TUBERCOLOSIS Agis Terzidis, Paediatrician Spyridon Gialamas, Medical Doctor SEMINAR ON TROPICAL AND TRAVEL MEDICINE AT TTCIH IFAKARA 25 JUNE 2009.
Comprehensive M&E Systems
ACTION II AND III ACTION II: EXCHANGING RESEARCH EXPERIENCE AND KNOW-HOW ON EU-TURKEY RELATIONS Activity 1 CES-METU Fellowship Programme  To enable the.
DEPOCEI Development of Policy-Oriented Training Programmes in the Context of the European Integrations MAP OF THE ROAD Belgrade, January.
Name Speaker This work is part of the Joint Action on Improving Quality in HIV Prevention (Quality Action), which has received funding from the European.
Laboratory Capacity Building in Africa Tsehaynesh Messele, PhD CEO, ASLM.
Unit 9. Human resource development for TB infection control TB Infection Control Training for Managers at National and Subnational Level.
Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS.
DRUG-RESISTANT TB in SOUTH AFRICA: Issues & Response _ ______ _____ _ ______ _____ ___ __ __ __ __ __ _______ ___ ________ ___ _______ _________ __ _____.
Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS.
What is RECOVEU? An international partnership of educators and practitioners working in the field of drug addiction. Partners are based in the UK, Ireland,
CEI Consultation on the European Technology Platform Food for Life: Optimising regional benefit Dr Kitti Németh VUP Food Research Institute, Bratislava,
THE ROLE OF STOP TB GHANA PARTNERSHIP Chief Austin A. Obiefuna National Coordinator SECRETARIAT CO-HOSTED BY AFRO GLOBAL ALLIANCE (GH) & GHANA SOCIETY.
CPTR Key Accomplishments: Research Resources Group October 3, 2012.
TASK FORCE ON RETOOLING STOP TB PARTNERSHIP Cape Town November 2007.
FORESTUR: “Tailored training for professionals in the rural tourist sector” ES/06/B/F/PP VALORISATION & SUSTAINABILITY STRATEGY Florence, January.
FORESTUR: “Tailored training for professionals in the rural tourist sector” ES/06/B/F/PP VALORISATION & SUSTAINABILITY STRATEGY Sucevita, May 2008.
Dr. Margaretha Mazura (EMF) ICT Day Opportunities to participate in EU ICT research projects San José, 16 February 2010 Principles of EU Research Funding.
DEMOCRACY, CITIES AND DRUGS II Thematic Platforms Presentation Young wanderers and drugs Presentation ANIT is the French federation of health centres and.
1 Women Entrepreneurs in Rural Tourism Evaluation Indicators Bristol, November 2010 RG EVANS ASSOCIATES November 2010.
SPIRIT Energising Faith Communities Contract number: IEE/13/524/SI Project duration: 30 months Last modified:
ERASMUS FOR ALL EUROPEAN FUNDED PILOT PROJECT WORK PACKAGES / DELIVERABLES PRESENTED BY DR SHYAM PATIAR.
Orphanet Europe State of the Art of Database and Services Polish activity Orphanet Europe State of the Art of Database and Services Polish.
1 SMEs – a priority for FP6 Barend Verachtert DG Research Unit B3 - Research and SMEs.
Issue : 2 August 2013 Aim of the LITSSW project: People living in and/or immigrating to another country who do not speak the local language often are faced.
Epidemiologic Studies Consortium Research CTCA meeting October 22, 2010 Lisa Pascopella, PhD, MPH California Department of Health Services.
WP8 – Innovation Support Kelly Vavasi General Secretariat for Research and Technology (GSRT) 1 st Innovation Dialogue Forum Becici, 8-9 November 2010.
The European Innovation Partnership for asthma: an opportunity for change Samantha Walker PhD, Asthma UK Project Coordinator, EARIP (European Asthma Research.
Summary of Local Seminars & Focus Groups 20/06/ Athens WP8 – TESTING II coordinated by IFI.
Participation in 7FP Anna Pikalova National Research University “Higher School of Economics” National Contact Points “Mobility” & “INCO”
GENOMICS TO COMBAT RESISTANCE AGAINST ANTIBIOTICS IN COMMUNITY-ACQUIRED LRTI IN EUROPE (GRACE) H. Goossens (Coordinator), K. Loens (Manager), M. Ieven.
Jean-Michel Courades, DG AGRI F3 European Rural Development Network
1 [INSERT SPEAKER NAME DATE & LOCATION HERE] Ethics of Tuberculosis Prevention, Care and Control MODULE 7: GAP BETWEEN AVAILABILTY OF DRUG SUSCEPTIBILITY.
P5 Work Package 5 - Dissemination (WP5) Overall responsibility to ensure the timely achievement of the targets and deliverables for this WP – page 19.
EARIP Stakeholder Workshop Models and healthcare systems: transferability of best practice across Europe Dr. Aurélien PEREZ European Commission Health.
Strengthening of continues medical education system in SRH&R Aigul Azimova Kyrgyz State Medical Institute for Retraining and Continuous Education Bishkek.
WP6 – Dissemination Project Name: Enhancing Students Participation in Quality Assurance in Armenian HE- ESPAQ Ref TEMPUS BE-TEMPUS-SMGR.
1 Supporting research collaboration between SMEs and Academia in the Health area of FP7 SMEs go Health Dr Cristina Pascual National.
Public health, innovation and intellectual property 1 |1 | The Global Strategy on Public Health, Innovation and Intellectual Property Technical Briefing.
GENOMICS TO COMBAT RESISTANCE AGAINST ANTIBIOTICS IN COMMUNITY-ACQUIRED LRTI IN EUROPE (GRACE) H. Goossens (Coordinator), K. Loens (Manager), M. Ieven.
EARIP- European Asthma Research and Innovation Partnership Dr Samantha Walker (Asthma UK) “Does innovative research for allergy and respiratory disease.
Matthias Wentzlaff-Eggebert, BZgA This work is part of the Joint Action on Improving Quality in HIV Prevention (Quality Action), which has received funding.
The 7th Framework Programme for Research: Strategy of international cooperation activities Robert Burmanjer Head of Unit, “International Scientific Cooperation.
Early DETECTion and integrated management of TuBerculosis in europe: E-DETECT TB Professor Ibrahim Abubakar Director, Institute for Global Health University.
C2ME Main findings Jeanine Suurmond, AMC, dept of Public Health, Project leader C2ME 18 September 2015 ‘Culturally Competent In Medical Education’ Amsterdam.
About the European Science Foundation 1. 2 ESF Member Organisations ESF is an independent association of 13 Member Organisations ● research funding organisations.
Ministry Of Education and Higher Education National Tempus Office Palestine TEMPUS PROGRAM PREPARED BY National Tempus Office – Palestine 2010 European.
 The Work of Civil Society in the Field of HIV Prevention Brussels, 23 February 2011 The Work of European AIDS Treatment Group (EATG) 1.
2. The funding schemes ICT Proposer’s Day Köln, 1 February 2007 The ICT Theme in FP7 How to participate to ICT in FP 7.
World Tuberculosis Day 2016 Monitoring the implementation of the Framework Action Plan to Fight Tuberculosis in the European Union – Situation in 2014.
NatRisk WP-6: Dissemination
World Tuberculosis Day 2014
11 viii. Develop capacity for signal detection and causality assessment Multi-partner training package on active TB drug safety monitoring and management.
12. Role of national and international technical and funding partners in the implementation of aDSM Multi-partner training package on active TB drug safety.
Dan Tofan | Expert in NIS 21st Art. 13a WG| LISBON |
The ERA.Net instrument Aims and benefits
World Tuberculosis Day 2016
World Tuberculosis Day 2014
The Role of NICs in Influenza Surveillance
The International Consortium for Personalised Medicine
Action Points 6 November 2007 Cape Town, South Africa
Roles of District Community-Directed Intervention (CDI) Team Members
11 iii. Define management and supervision roles and responsibilities
Presentation transcript:

Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS for your personal use only, as submitted by the author.  2010 by the author

TB PAN-NET Project: goals, role of ERS, what we expect from you Rosella Centis

TB PAN-NET: Pan‐European network for study and clinical management of drug resistant tuberculosis European consortium of 27 expert partners in the field of drug resistant tuberculosis. Funded by the European Commission (FP7) Duration: from January 2009 to December 2013 The aim is to coordinate activities to limit the spread of MDR strains by supporting high quality epidemiological and molecular analysis as well as training on MDR-TB. Consortium outputs will assist governments in the development and implementation of appropriate health and social policies to limit and control the spread of MDR-TB within the member states of the EU.

Structure The project is built around eight different work packages: WP1: Molecular epidemiology of drug-resistant strains in selected metropolitan settings in Western and Eastern Europe WP2: Characterization of novel mutations involved in drug-resistant phenotype and virulence markers WP3: Development and standardization of EQA for drug-resistant TB and expansion of capability for culture-based and molecular-based techniques for drug-resistant TB WP4: Development of integrated sites for clinical and diagnostic trials of new drug applications, new diagnostics, and development of markers for treatment success, and identify clinical and social factors, including HIV as markers of resistance WP5: Training on TB clinical management, control and research (FSM) WP6: TBNET: Clinical research on TB drug-resistance in Europe WP7: Dissemination and information sharing (ERS) WP8: Management

Work Package 5 – Goal & Objectives Goal: Provide quality education and training on TB DR and in particular MDR-TB for TB managers and Western and Eastern European clinicians in order to develop the human resources on TB and thus curb the drug-resistant TB epidemic mainly by using available tools. Objectives: 1.Develop a set of modules and materials based on international standards and requirements and revise them after field testing 2.Conduct training courses for managers of national /sub-national TB and TB/HIV programmes, agencies and NGOs involved in MDR-TB programmes in EU with special focus on Eastern European countries and globally. 3.Educate and train European respiratory clinicians and specialists on state-of-the-art management and control of MDR- and XDR-TB on the basis of the materials and modules from Objective 1 (in collaboration with ERS)

WP5: objective 3 Task: Organize in collaboration with the ERS School training targeting mainly respiratory clinicians and specialists dealing with TB-patients in Eastern Europe and former Soviet countries using different methodologies and modalities : – ERS External School courses – ERS School Seminars – ERS Postgraduate Courses on MDR- and XDR-TB The courses are based on the MDR/XDR modules and materials developed by FSM easily adaptable to different settings

ERS PG course on “Training of Trainers” (ToT) For the first time ERS will train facilitators to be used in ERS PG courses, External School courses and seminars. This will allow delivering a quality and standardized training relying on a pool of qualified facilitators.

Why the Training of Trainers session? Availability of an adequate number of specifically trained human resources is a key point to ensure management and control of TB DR and in particular MDR-TB The goal of this session is to prepare 25 tuberculosis trainers who will train medical doctors from Eastern Europe and former Soviet countries Trainings for medical doctors to fight with MDR-TB will be organised by the ERS in collaboration with local societies Trained medical doctors will be able to carry out quality medical practice in their countries and to train others in how DR-patient management should be done ToT course is giving tips on how to deliver an effective presentation by using standardized materials with added value (presentations personalised modifying up to 20% of the slides)

This initiative is Supervised by the ERS School of Respiratory Medicine. and coordinated with: the European Diploma in Respiratory Medicine (Hermes project) the ERS MD PhD programme in Respiratory Science the ERS series of online CME modules

Map of participants

Role of ERS ERS is the partner to organise ToTs ERS is leading WP 7 (information dissemination and sharing): – TB symposium – Website – Newsletters – Press-conferences – Assist with PGs, seminars, courses....

What we expect from you To be willing to participate as a speaker/facilitator in the ERS School courses around the EU at least once a year (maximum twice) until 2014 To be able to replicate the course without the support of TB PAN-NET and ERS To train people in your countries based on standardized material of ToT

How is the ToT conducted? The TB PAN-NET Project (WP 5) has developed a competence- based training package composed of 3 Manuals (Participant, facilitator and course director including 3 Parts and 28 Units). One of these Units is specifically addressing MDR- /XDR-TB. The core of this Unit has been mailed to you before the training. You have been given instructions on how to personalize it, adding up to 20% of slides. What slides may you want to add? These slides may include pictures and animations you are familiar with, as well as studies/reports than you feel are useful to focus your presentation to a specific country and/or audience.

The ToT will have the following scheme The rational and background for it will be provided Some tips on how to deliver an effective presentation will be suggested The structure of the MDR/XDR-TB presentation will be summarized An example of personalized presentation will be provided by a ERS speaker Some examples of personalized presentations will be provided by ToT participants, followed by plenary discussion